DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Our Mission

Druglib.com strives to provide the most comprehensive and accurate single source of information of prescription and over the counter medications available. Our intention is to provide a valuable resource for both healthcare professionals and layman by providing drug information, related news, research, available clinical trials and more.

With the exeption of appropriately marked user feedback/comments, we obtain information form only the most reputable sources, including government, educational and industry; however we take no responsibility for the accuracy of the data. Please see the site usage policy for further details. The information provided on Driglib.com is for reference purposes only and users should consult a physician for individual healthcare needs.

Advertising policy

We accept advertising from multiple sources and will make every effort to screen out any disreputable advertisers; however we accept advertising from advertising aggregators and therefore can not endorse any advertiser that appears on the site.

All advertizing on the site is clearly labeled as such.

Online pharmacies

We do not sell medications and we do not have a relationship with any online drug store.

In the last few years there has been a proliferation of companies and individuals selling medications on the Internet. Many of these sources are often disreputable. Druglib.com does not endorse the purchase of prescription medications over the Internet from any specific vendor.

Users should be aware of the dangers of purchasing prescription medication on the Internet. For further information please refer to the following sources:

Editorial Board of Advisors

Vitaly Rogalsky, M.D., Ph.D., Doctor of Medical Sciences

President and chief scientific officer of Leukostem Laboratory, LLC in New York. Formerly, professor at the Mount Sinai School of Medicine, New York, NY. Distinguished researcher in the fields of oncology and cell growth regulation. In particular, conducted pioneering studies of cancer-embryonic antigen, the first diagnostically significant cancer marker. Author/co-author of numerous scientific publications in prestigious journals, including Nature.

Igor N. Todorov, Ph.D., Doctor of Biochemistry

Professor of Biochemistry and Lead Researcher at the Institute of Chemical Physics of the Russian Academy of Sciences. Author of major discoveries in the fields of biochemistry, cell & molecular biology and pharmacology. Achievements include pioneering work in the physiology of growth hormone, radiation sickness, pharmacology of adaptogens, cellular stress and others. Authored/co-authored over a hundred scientific papers and monographs. Authored a feature article in the prestigious Scientific American magazine.

Ownership and Funding

Druglib.com is privately owned and funded and is not affiliated with any manufacturer, merchant, or advocacy group.


We welcome your suggestions and feedback. To contact us please see the contact us page.

Page last updated: 2009-05-30

Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017